Trial Profile
To demonstrate the safety of tenofovir in patients with chronic hepatitis-B who are on hemodialysis and had renal transplant.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2015 New trial record